On Jan. 04, Schlanger David J divested U.S. $4,268,072 in shares of Progyny Inc.. The CEO sold 100,010 shares at a price per share of $42.68. The transaction decreased this specific insider’s holdings to 200,002 shares worth around $8.68 million at present.
Another 63,000 shares were sold by Anevski Peter, for more than $2,695,539 in total proceeds. The Pres, COO dumped the shares at a price of $42.79 and the insider now owns almost 939,146 shares.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
SVB Leerink launched its Progyny Inc. [PGNY] rating to the equivalent of an Outperform and assigned the price target of $35, in a research note dated July 01, 2020. That figure represents around a -24.0% premium from where the company’s shares closed on Wednesday. Some new analysts also started their coverage, with SVB Leerink’s analysts assigning the shares to “an Outperform” rating in a research note to investors issued in early July. Meanwhile, Guggenheim had launched its coverage on PGNY with “Buy”, in a research note produced for clients June 02, 2020. In addition, there was a new coverage from SVB Leerink on November 19, 2019. The research firm rated PGNY “an Outperform”.
Is Progyny Inc. [NASDAQ:PGNY] a Good Buy Right Now?
It should be noted that PGNY technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 100% Buy in the last week and compares with 100% Buy in the past month. Data from Progyny Inc.’s Trend Spotter indicated that the signals were Strengthening. The stock current average is 0.88 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.87 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.8 million shares.
PGNY Price Performance
On Wall Street, Progyny Inc. [NASDAQ:PGNY] finished Wednesday’s session up 1.85% at $43.40. The stock went up to $44.24 at the same session while its lowest single day price was $42.16. In the last five days, it saw a rise of about 2.50%, Progyny Inc. shares gained by almost 2.38% since the beginning of the year. However, the share price has dropped to as low as -1.85% below its one year high. On 01/06/21, the company shares recorded $44.24, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $41.31. The company’s shares have inclined by 48.02% in the past year. The 50-day SMA achieved is $34.58 while the 200-day SMA is $27.73. Volume gained to 0.67 million from 0.6 million in the previous session.
Progyny Inc. [PGNY] Valuation Measures
Notably, Progyny Inc. [PGNY] stock can be helpful for investors to consider historical price-sales ratio, more specifically, a 12.34 PS value ratio is reported for the last one year of reported earnings. That is higher than the industry average of 2.23.
PGNY Stock Support And Resistance Levels
On the 24-hour scale, the immediate backing is perceived around 42.29 level, and in case of violation of this particular level, it will cause more drop to 41.19 level. On the upper level, 45.35 is still the key resistance. The stock may increase to the subsequent resistance at 44.37. The Relative Strength Index (RSI) pinned on the 14-day chart is 73.99, implying a overbought technical stance while the MACD stands at 1.27, meaning price will increase in the next trading period. Percent R indicator moved to 14.71%, implying bullish price movement. Stochastic %K at 78.17% suggest holding the stock.
What is the short interest in Progyny Inc.?
Short interest in the Progyny Inc. stock has plunged, decreasing by -0.31 million shares to total 2.92 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 2.61 million, data from Yahoo Finance shows. The increase of 10.62% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 22.32% of the overall float for the stock.
Progyny Inc.’s Biggest Shareholders: Who Owns Progyny Inc. [PGNY]?
Filings by Macquarie Investment Management B showed that the firm now holds a total of 4,857,751 shares or roughly 5.61% of the outstanding PGNY shares. This means their shares have increased by 1,344,978 from the 4,857,751 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, Fred Alger Management LLC updated stake is worth $141,825,990. Details in the latest 13F filings reveal that The Vanguard Group, Inc. acquired their 34.97% stake valued at $117,562,116 while ClearBridge Investments LLC added theirs at $89,655,619. During the last quarter, The Vanguard Group, Inc. raised 858,348 of its shares in Progyny Inc. while ClearBridge Investments LLC bought 596,110 shares. The Weatherbie Capital LLC’s holdings currently number 2,028,582 shares at $88040458.8. According to the firm’s last 13F report, BlackRock Fund Advisors shares in the company at filing stood at 1,693,384 shares, roughly $60,098,198.
PGNY Earnings Forecast For The Current Quarter
Progyny Inc. [PGNY] is expected to report strong earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $98.03M and an earnings per share of $0.06 for Dec 2020. Looking further ahead, the company is expected to report revenue of $125.75M at an EPS of $0.11 for Mar 2021. The estimates represent upside of 56.90% and 189.93% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.
PGNY Earnings Estimates For The Current Year
For the financial year, Progyny Inc. [NASDAQ:PGNY] is expected to bring in revenue of $342.75M. The returns are nearly $113.07 million higher than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 0.14, higher than that of FY19 by $0.03. Estimates put this year’s earnings growth at 27.30%, 185.70% for the next, and at an annual 69.70% over the next 5-year period. As for sales, forecasts are for an increase of 49.20% in the current fiscal year and a further 56.90% over the following year.
What are analyst thoughts on Progyny Inc.?
Looking forward to the Progyny Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for Progyny Inc. stock at $45.50 within the next 12 months, which represents almost 4.62 per cent growth from its previous closing price of $43.40. The highest analysts’ target for Progyny Inc. stock projections is $50.00 and the lowest one is $44.00. Still, 4 analysts sharing their consensus rating for PGNY stock in 2021 agree that it is an Overweight.